Key Segmentation:
By Product
-
Transfection Reagents
-
Transfection Equipment
By Transfection Method
-
Lipid-Mediated/Chemical Transfection
-
Electroporation
-
Viral Transduction
-
Calcium Phosphate
-
Polymer-Based
-
Microinjection
-
Others
By Application
-
Basic Research
-
Gene Therapy
-
Drug Discovery & Development
-
Protein Production
-
Cell Line Development
-
Vaccine Development
-
Others
By End User
-
Pharmaceutical & Biotechnology Companies
-
Academic & Research Institutes
-
Contract Research Organizations (CROs)
-
Hospitals & Clinical Laboratories
-
Others
Regional Coverage:
North America
-
United States
-
Canada
Europe
-
Germany
-
United Kingdom
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization:
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
The Transfection Reagents and Equipment Market is expected to grow at a CAGR of 8.04% from 2026 to 2035.
The Transfection Reagents and Equipment Market was valued at USD 1.71 Billion in 2025.
Rising R&D expenditure by pharmaceutical and biotechnology companies in gene therapy clinical programmes requiring GMP-grade transfection reagents and equipment, and mRNA therapeutic platform expansion creating premium lipid nanoparticle transfection reagent demand from personalised medicine and RNA therapy programmes.
Transfection Reagents dominated the market with approximately 74% share in 2025, while the Transfection Equipment segment is the fastest growing.
North America dominated the Transfection Reagents and Equipment Market in 2025 with approximately 42% of global revenues, with the United States accounting for approximately 87.4% of North American revenues.